Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2008-08-26Clinical Trial Update: Treatment of Cheyne Stocks Respiration With Adaptive Servo Ventilation and Bilevel Ventilators in Patients With Chronic Heart Failure
A clinical trial update examining the use of adaptive servo ventilation and bilevel ventilators to treat Cheyne-Stokes respiration in patien…
-
FDA approval · 2008-08-22FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))
FDA approved a supplemental application for lisinopril from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. to market a generi…
-
FDA approval · 2008-08-22FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Solco healthcare U.S., LLC)
The FDA granted supplemental approval for a benazepril hydrochloride product (Solco Healthcare U.S., LLC), a generic ACE inhibitor used to m…
-
FDA approval · 2008-08-22FDA Approved: CARVEDILOL — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for CARVEDILOL from Dr. Reddy's Laboratories Limited, authorizing its generic carvedilol product for…
-
CLINICAL_TRIALS research · 2008-08-19Clinical Trial Update: Combined CABG and Stem-Cell Transplantation for Heart Failure [Phase 2]
Phase 2 clinical trial evaluating combined coronary artery bypass grafting and stem-cell transplantation for heart failure is in progress; c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-08-18Clinical Trial Update: Longitudinal Surveillance Registry
The Longitudinal Surveillance Registry trial sponsored by Boston Scientific was terminated. The study focused on heart failure and sudden ca…
-
FDA approval · 2008-08-15FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (Exelan Pharmaceuticals Inc.)
The FDA approved Exelan Pharmaceuticals Inc.'s original application for hydrochlorothiazide, a generic diuretic indicated for hypertension a…
-
FDA label_change · 2008-08-14FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Amici Pharma, Inc)
FDA approved a supplemental application for enalapril maleate from Amici Pharma, Inc., resulting in labeling changes for the product.
-
CLINICAL_TRIALS trial_result · 2008-08-01Clinical Trial Update: Biomarkers in Acute Heart Failure
The trial update notes that a study on biomarkers in acute heart failure has completed, aiming to identify diagnostic or prognostic biomarke…
-
FDA approval · 2008-07-31FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for the lisinopril and hydrochlorothiazide combination from Actavis Pharma, Inc. The approval covers…
-
CLINICAL_TRIALS research · 2008-07-16Clinical Trial Update: The Effect of Left Ventricular Filling Pressure on Pulmonary Clearance of Free Radical Loaded White Blood Cells and Platelets in Congestive Heart Failure Patients Before and After Biventricular Pacing
This clinical trial update investigates how left ventricular filling pressure affects pulmonary clearance of free radical-loaded white blood…
-
CLINICAL_TRIALS trial_result · 2008-07-08Clinical Trial Update: Cardiac Output Pulmonary Arterial Catheter Compared to FloWave™ 1000
This completed clinical trial compares a Cardiac Output Pulmonary Arterial Catheter with FloWave 1000 in patients with heart failure and rel…
-
CLINICAL_TRIALS research · 2008-07-04Clinical Trial Update: Diuretic Efficacy of Dexamethasone in Heart Failure [Phase 1]
A Phase 1 trial assessing the diuretic effect of dexamethasone in heart failure (congestive) is currently suspended. The study is sponsored …
-
CLINICAL_TRIALS trial_result · 2008-07-02Clinical Trial Update: Nocturnal Oxygen Treatment in Heart Failure and Cheyne-Stokes Respiration [NA]
This clinical trial evaluating nocturnal oxygen treatment in heart failure with Cheyne-Stokes respiration has completed.
-
CLINICAL_TRIALS trial_result · 2008-06-23Clinical Trial Update: Health E Heart Study (South Texas Veterans Health Care System Heart Failure Disease Management Program/Study) [Phase 4]
Phase 4 clinical trial update for the Health E Heart Study focusing on heart failure disease management in the South Texas Veterans Health C…
-
FDA approval · 2008-06-20FDA Approved: RAMIPRIL — Original Application (GSMS, Incorporated)
FDA approved RAMIPRIL as a generic drug under an original Abbreviated New Drug Application (ANDA 079116) filed by GSMS, Incorporated.
-
CLINICAL_TRIALS trial_result · 2008-06-19Clinical Trial Update: N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure [Phase 4]
Phase 4 trial evaluating whether N-3 fatty acids can prevent atrial fibrillation in patients with acute heart failure.
-
FDA approval · 2008-06-18FDA Approved: RAMIPRIL — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original ANDA for ramipril, authorizing the marketing of a generic ramipril product.
-
FDA approval · 2008-06-18FDA Approved: RAMIPRIL — Original Application (Chartwell RX, LLC.)
The FDA approved Chartwell RX, LLC's original generic application for ramipril, enabling the marketing of a RAMIPRIL product.
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT). [Phase 2]
A completed Phase 2 safety study evaluating a vasopressin V2 receptor antagonist in patients with severe chronic heart failure (AQUAVIT), sp…
-
CLINICAL_TRIALS trial_result · 2008-06-11Clinical Trial Update: Pain Assessment, Incidence & Nature in Heart Failure
A completed clinical trial update examining pain assessment, incidence, and nature in heart failure patients. The study status is completed.
-
CLINICAL_TRIALS research · 2008-06-05Clinical Trial Update: Skeletal Muscle Oxygenation in Critically Ill
A clinical trial update from University Medical Centre Ljubljana examining skeletal muscle oxygenation in critically ill patients, including…
-
FDA label_change · 2008-05-29FDA Approved: LOTENSIN — Supplemental Application (Validus Pharmaceuticals LLC)
FDA Supplemental Application for Lotensin (benazepril hydrochloride) submitted by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2008-05-14Clinical Trial Update: Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study [Phase 3]
The PHANTOM trial, a Phase 3 pilot study comparing metformin to placebo in patients with heart failure and type 2 diabetes, was terminated.
-
FDA approval · 2008-05-09FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for torsemide by Chartwell RX, LLC, updating an approved generic product (ANDA).